BERLIN (dpa-AFX) – With a view to setting up a research and development center for the pharmaceutical company Biontech (BioNTech (ADRs)) in Great Britain, Federal Education Minister Bettina Stark-Watzinger is concerned about Germany as a research location. “Biontech is not completely migrating, but that should give us food for thought in Germany and Europe,” said the FDP politician to the “Augsburger Allgemeine” (Saturday). “Despite the turning point, we have to work consistently on our competitiveness, reduce bureaucracy and remain open to technology.” A welcoming culture for innovations is needed more than ever.
With the future strategy for research and innovation, a cross-departmental foundation is being created “to pool the efforts and resources of the federal government and to focus them on the major challenges”.
The Mainz-based pharmaceutical company Biontech announced in early January that it wanted to set up a research and development center for cancer therapy in Great Britain. It also wants to take over a British start-up specializing in artificial intelligence.
Stark-Watzinger explained that the Helmholtz Institute in Mainz with Biontech founder Ugur Sahin is still researching immunotherapy against cancer in Germany./red/DP/stw
Leverage must be between 2 and 20
No data